首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1447815

全球伴侶動物藥物市場規模、佔有率、成長分析，依藥物（抗生素、抗發炎藥物）、依動物（狗、貓）分類 - 產業預測 2024-2031

Global Companion Animal Drugs Market Size, Share, Growth Analysis, By Medicine(Antibiotics, Anti-inflammatory Drugs), By Animal(Dogs, Cats) - Industry Forecast 2024-2031

出版日期: 2024年02月28日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球伴侶動物藥物市場規模為139.9億美元，預計將從2023年的149.4億美元成長到2031年的252.9億美元，預測期間（2024-2031年）複合CAGR為6.8%。

受全球寵物家庭數量不斷增加、寵物保健意識增強以及獸藥進步等因素推動，全球伴侶動物藥品市場大幅成長。寵物數量的增加促使對狗、貓等伴侶動物的藥物和治療的需求激增。推動這一成長的重要因素包括更加重視預防保健，例如疫苗接種和寄生蟲控制，以及擴大慢性病的治療選擇範圍。此外，市場見證了藥物傳遞方法和配方的創新，例如調味片劑和局部治療劑，使寵物主人的給藥變得更容易。隨著寵物主人繼續優先考慮他們心愛的動物的健康和福祉，伴侶動物藥物市場預計將繼續呈上升趨勢。這為製藥公司和獸醫提供了滿足這一不斷成長和繁榮的市場需求的機會。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Zoetis Inc. (USA)
Elanco Animal Health Inc. (USA)
Merck & Co., Inc. (USA)
Boehringer Ingelheim (Germany)
Bayer AG (Germany)
Virbac (France)
Ceva Sante Animale (France)
Vetoquinol SA (France)
Nexvet (USA)
IDEXX Laboratories, Inc. (USA)
Biogenesis Bago (Argentina)
Nutramax Laboratories, Inc. (USA)
Heska Corporation (USA)
Merial (Sanofi) (France)
Animalcare Group PLC (United Kingdom)
Kindred Biosciences (USA)
Norbrook Laboratories (Ireland)
Kyoritsu Seiyaku Corporation (Japan)
TVM Laboratories (France)
Dechra Pharmaceuticals PLC (United Kingdom)

簡介目錄

Product Code: SQMIG35I2251

Global Companion Animal Drugs Market size was valued at USD 13.99 Billion in 2022 and is poised to grow from USD 14.94 Billion in 2023 to USD 25.29 Billion by 2031, at a CAGR of 6.8% during the forecast period (2024-2031).

The global market for companion animal drugs has seen substantial growth, driven by factors such as the increasing number of households with pets worldwide, heightened awareness of pet healthcare, and advancements in veterinary pharmaceuticals. The rise in pet ownership has led to a surge in demand for medications and treatments for companion animals, including dogs, cats, and others. Important factors propelling this growth include a greater emphasis on preventive care, such as vaccinations and parasite control, as well as an expanding range of therapeutic options for chronic conditions. Moreover, the market has witnessed innovations in drug delivery methods and formulations, such as flavoured tablets and topical treatments, making administration easier for pet owners. As pet owners continue to prioritize the health and well-being of their beloved animals, the companion animal drugs market is anticipated to continue its upward trend. This presents opportunities for pharmaceutical companies and veterinarians to meet the needs of this growing and flourishing segment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Companion Animal Drugs and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Companion Animal Drugs Market Segmental Analysis

The global companion animal drugs market can be segmented into several categories based on factors such as drug, animal, and region. Drug types include antibiotics, anti-inflammatory drugs, parasiticides, and others, while animal types encompass dogs, cats, and others. Geographically, the market can be divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Drivers of the Global Companion Animal Drugs Market

The companion animal drugs market is experiencing growth driven by advancements in veterinary medicine, including the development of improved diagnostics, treatments, and pharmaceuticals. These advancements have led to a broader range of treatment options and better disease management, increasing the demand for advanced companion animal medications.

The market for companion animal drugs is rapidly expanding due to shifting global preferences towards pet ownership. More individuals are adopting dogs and cats, leading to a heightened focus on pet healthcare and pharmaceuticals. This trend has resulted in increased financial investment in improving pet health. Owners, deeply connected to their pets, prioritize their well-being and are willing to invest in companion animal drugs.

Restraints in the Global Companion Animal Drugs Market

The companion animal drugs market is facing a significant challenge in the form of financial burdens associated with these medications and treatments. The high costs may discourage consumers from investing in pet health, potentially delaying or hindering market adoption. Pet owners, particularly those in low-income areas or with limited budgets, may find the expenses of these costly healthcare options for their animals to be prohibitive.

Regulatory bodies tightly control the companion animal drugs market. Compliance with strict rules and obtaining approvals for production and distribution can pose challenges for market players. These stringent requirements can consume a significant amount of time, resulting in a lengthy and expensive process overall. The demanding task of securing approvals and maintaining compliance during development can be arduous, potentially limiting new product entries and causing delays in innovation, which could have negative impacts on the market.

Market Trends of the Global Companion Animal Drugs Market

Digital Health Innovations: The field of veterinary medicine is undergoing changes with the adoption of data analytics and other digital technologies. Wearable devices, telehealth services, and mobile apps have become integrated into veterinary care. These advancements enable pet owners to remotely monitor their pets' health indicators and facilitate communication with consulting veterinarians. Additionally, these technologies aid in managing medication prescriptions with precision.

Emergence of Specialty and Personalized Medications: The companion animal drug market has undergone a significant shift as pet owners increasingly seek personalized and advanced medications for their cats and dogs. Pharmaceutical companies and veterinarians are adapting to this trend by tailoring treatments to suit the diverse health conditions of various animal breeds and sizes. Customized medications are viewed as a potential solution for more effective and precise therapies, with accessibility growing to meet the rising demand.

Focus on Preventive Care: Another notable trend influencing the pet drug industry is the increased emphasis on preventive care for pets. In response to this trend, market players are emphasizing the development and promotion of various products, including wellness and parasite control products, as well as advanced vaccines. Pet owners are prioritizing the health and overall well-being of their pets, leading to a growing demand for preventive medicines.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Companion Animal Drugs Market by Medicine

Market Overview
Antibiotics
Anti-inflammatory Drugs
Parasiticides
and others

Global Companion Animal Drugs Market by Animal

Market Overview
Dogs
Cats
and others

Global Companion Animal Drugs Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Zoetis Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceva Sante Animale (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetoquinol S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexvet (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDEXX Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogenesis Bago (Argentina)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nutramax Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Heska Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merial (Sanofi) (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Animalcare Group PLC (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kindred Biosciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norbrook Laboratories (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kyoritsu Seiyaku Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TVM Laboratories (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dechra Pharmaceuticals PLC (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments